ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,558,352, issued on Feb. 24, was assigned to Institute of Basic Medical Sciences, CAMS (Beijing).
"Use of malic enzyme 1 (ME1) in preparation of drug for preventing and treating pulmonary hypertension (PH)" was invented by Jing Wang (Beijing), Yanjiang Xing (Beijing), Ya Luo (Beijing) and Xianmei Qi (Beijing).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure belongs to the technical field of biomedicine, and specifically relates to use of a malic enzyme 1 (ME1) inhibitor in preparation of a drug for preventing and treating pulmonary hypertension (PH) and as a marker for detecting and/or treating the PH. Since a protein level and/or an ...